Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» autoimmune diseases
autoimmune diseases
Seismic Therapeutic doses healthy subject cohort in Phase I trial of S-4321
Clinical Trials Arena
Fri, 04/11/25 - 11:23 am
Seismic Therapeutic
clinical trials
S-4321
autoimmune diseases
Sanofi taps Nurix for pipeline nourishment once again, picking up autoimmune degrader for $15M
Fierce Biotech
Wed, 04/2/25 - 11:40 am
Sanofi
Nurix Therapeutics
autoimmune diseases
protein degradation
Sanofi to acquire Dren Bio’s immunology unit
Investing.com
Thu, 03/20/25 - 11:25 am
Sanofi
Dren Bio
immunology
DR-0201
M&A
autoimmune diseases
Cell therapy biotech Century Therapeutics axes cancer trial, turns to autoimmune
Fierce Biotech
Thu, 03/20/25 - 11:11 am
Century Therapeutics
cell therapy
cancer
autoimmune diseases
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
Motley Fool
Thu, 08/29/24 - 11:10 am
IPOs
Artiva
autoimmune diseases
cell therapy
AlloNK
Japan's Ono Pharma taps Texas startup Shattuck for $227M bifunctional fusion protein deal
Fierce Biotech
Wed, 02/14/24 - 11:33 am
Ono Pharmaceutical
Shattuck Labs
fusion proteins
biobucks
autoimmune diseases
Kyverna IPO adds to biotech momentum with $319M fundraise
BioPharma Dive
Thu, 02/8/24 - 11:07 am
Kyverna Therapeutics
IPOs
autoimmune diseases
Gilead-backed Kyverna Therapeutics aims for $857.3 mln valuation in upsized IPO
Reuters
Tue, 02/6/24 - 09:17 am
Kyvera Therapeutics
IPOs
Gilead Sciences
autoimmune diseases
Immunovant shares surge as early antibody treatment data beats expectations
Yahoo/Reuters
Tue, 09/26/23 - 11:43 am
Roivant
Immunovant
antibodies
clinical trials
IMVT-1402
autoimmune diseases
Takeda wagers up to $6B on Nimbus’ TYK2 drug
BioPharma Dive
Tue, 12/13/22 - 10:43 am
Takeda
Nimbus Therapeutics
autoimmune diseases
NDI-034858
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
BioSpace
Wed, 10/19/22 - 10:44 am
Nucleome Therapeutics
funding
precision medicine
autoimmune diseases
Pfizer
JNJ
Merck KGaA
autoimmune disease